Sales reported at Rs 0.17 crore
Net Loss of Venmax Drugs & Pharmaceuticals reported to Rs 0.30 crore in the quarter ended September 2024 as against net loss of Rs 0.03 crore during the previous quarter ended September 2023. Sales reported to Rs 0.17 crore in the quarter ended September 2024. There were no Sales reported during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales0.170 0 OPM %-176.470 -PBDT-0.30-0.03 -900 PBT-0.30-0.03 -900 NP-0.30-0.03 -900Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content